Literature DB >> 23863161

Akt/mTOR signalling in myelination.

Camilla Norrmén1, Ueli Suter.   

Abstract

Akt signalling has emerged as one of the major pathways involved in myelination, implicated in the regulation of several steps during the development of myelinating Schwann cells and oligodendrocytes. One of the main pathways intimately linked with Akt is mTOR [mammalian (or mechanistic) target of rapamycin] signalling. Recent evidence suggests that many processes attributed to the Akt pathway in myelination depend, at least partly, on mTOR signalling. In the present mini-review, we summarize the major aspects of Akt/mTOR signalling and myelination, and how they appear to be linked. We focus on the PNS (peripheral nervous system), but also cover the key points of CNS (central nervous system) myelination, pointing out differences and similarities between the PNS and the CNS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863161     DOI: 10.1042/BST20130046

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  33 in total

1.  Schwann cell-specific deletion of the endosomal PI 3-kinase Vps34 leads to delayed radial sorting of axons, arrested myelination, and abnormal ErbB2-ErbB3 tyrosine kinase signaling.

Authors:  Anne M Logan; Anna E Mammel; Danielle C Robinson; Andrea L Chin; Alec F Condon; Fred L Robinson
Journal:  Glia       Date:  2017-06-15       Impact factor: 7.452

2.  Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle.

Authors:  Rashad Hussain; Wendy B Macklin
Journal:  J Neurosci       Date:  2017-01-11       Impact factor: 6.167

3.  Mice Deficient in lysophosphatidic acid acyltransferase delta (Lpaatδ)/acylglycerophosphate acyltransferase 4 (Agpat4) Have Impaired Learning and Memory.

Authors:  Ryan M Bradley; Emily B Mardian; Darin Bloemberg; Juan J Aristizabal Henao; Andrew S Mitchell; Phillip M Marvyn; Katherine A Moes; Ken D Stark; Joe Quadrilatero; Robin E Duncan
Journal:  Mol Cell Biol       Date:  2017-10-27       Impact factor: 4.272

4.  Deficiency of a membrane skeletal protein, 4.1G, results in myelin abnormalities in the peripheral nervous system.

Authors:  Yurika Saitoh; Nobuhiko Ohno; Junji Yamauchi; Takeharu Sakamoto; Nobuo Terada
Journal:  Histochem Cell Biol       Date:  2017-07-28       Impact factor: 4.304

5.  Daam2-PIP5K is a regulatory pathway for Wnt signaling and therapeutic target for remyelination in the CNS.

Authors:  Hyun Kyoung Lee; Lesley S Chaboub; Wenyi Zhu; Daniel Zollinger; Matthew N Rasband; Stephen P J Fancy; Benjamin Deneen
Journal:  Neuron       Date:  2015-03-05       Impact factor: 17.173

6.  Membrane Progesterone Receptors (mPRs/PAQRs) Differently Regulate Migration, Proliferation, and Differentiation in Rat Schwann Cells.

Authors:  Luca F Castelnovo; Lucia Caffino; Veronica Bonalume; Fabio Fumagalli; Peter Thomas; Valerio Magnaghi
Journal:  J Mol Neurosci       Date:  2019-11-20       Impact factor: 3.444

7.  The membrane palmitoylated protein, MPP6, is involved in myelin formation in the mouse peripheral nervous system.

Authors:  Yurika Saitoh; Akio Kamijo; Junji Yamauchi; Takeharu Sakamoto; Nobuo Terada
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

8.  Anemia in infancy is associated with alterations in systemic metabolism and microbial structure and function in a sex-specific manner: an observational study.

Authors:  Shannon McClorry; Nelly Zavaleta; Alejandro Llanos; Martin Casapía; Bo Lönnerdal; Carolyn M Slupsky
Journal:  Am J Clin Nutr       Date:  2018-12-01       Impact factor: 7.045

Review 9.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

Review 10.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.